JDRF Announces Manufacture of Affordable Insulin.
03 Mar 2022
We have some amazing news from our friends at JDRF:
We are thrilled to announce that JDRF International is supporting a new programme to develop affordable insulin in the US. Civica is a nonprofit generic drug manufacturing company founded by leading health systems. Expected to launch in 2024, this project will significantly lower the cost of insulin for millions of people and, most importantly, save lives.
Click on the article below to find out more: